AM Best TV Presents ‘Emerging Insurance Asset Investment Risks and Opportunities’
OLDWICK, N.J.–(BUSINESS WIRE)–#insurance–In the third installment of AM Best’s four-part cross-media series on asset management, insurance... Read more.
Best’s Market Segment Report: Rapidly Increasing Premiums in Managing General Agent Space Warrant Greater Oversight
OLDWICK, N.J.–(BUSINESS WIRE)–#insurance–Premium growth within the U.S. delegated underwriting authority enterprise (DUAE) segment grew at a double-digit... Read more.
Mainline Aviation Enhances Services With Final Mile Integration
Enhanced operations highlight commitment to operational and customer satisfaction ATLANTA–(BUSINESS WIRE)–Mainline Aviation, a premier provider of catering... Read more.
DIMERx Secures Global Rights to a Novel Amino Acid Prodrug Dimer Developed at Massachusetts General Hospital
Company to Pursue Applications in Rare Diseases and Proprietary Medical Food Domains Deal Unlocks Opportunities for Future Collaborations SAN FRANCISCO–(BUSINESS... Read more.
ChromaDex’s Niagen® Wins Prestigious NutraIngredients EU Healthy Ageing Ingredient of the Year Award
Judges award Niagen for its “high-quality, unparalleled” healthy aging research LOS ANGELES–(BUSINESS WIRE)–$CDXC #CellularHealth—ChromaDex... Read more.
Holley to Attend Upcoming Investor Conferences
BOWLING GREEN, Ky.–(BUSINESS WIRE)–Holley Performance Brands (NYSE: HLLY), a leader in automotive aftermarket performance solutions, today announced... Read more.
CAI and Fedegari Group Forge Strategic Partnership to Deliver Transformational Turnkey Sterilization Solutions to Pharmaceutical Manufacturers
CAI’s best-in-class verification and risk management practices combined with Fedegari’s innovative sterilization equipment and engineering to reduce cost and... Read more.
Actio Biosciences Appoints Ben Cravatt, Ph.D., to Board of Directors
SAN DIEGO–(BUSINESS WIRE)–Actio Biosciences, a biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop... Read more.
Gilead to Present Latest Research Across Key Liver Disease Indications at the European Association for the Study of the Liver Congress 2024
– Key Findings from PBC, HDV, HCV, HBV and MASH/Fibrosis Studies Affirm Commitment to Drive Life-changing Science in Liver Disease – FOSTER CITY, Calif.–(BUSINESS... Read more.
Digital Biomarkers Market Insights, Growth & Opportunity Outlook, 2024-2035: Quibim’s QP-Brain Leads Neurodegenerative Disorder Detection, AliveCor’s KardiaMobile Card Cleared for Rapid ECG Diagnosis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Digital Biomarkers Market: Industry Trends and Global Forecasts, till 2035: Distribution by Type of Product, Purpose... Read more.